Kellerhals Carrard acted for BKW AG while Homburger advised UBS Switzerland AG on the deal. BKW AG’s completed a new CHF 1 billion Swiss law governed...
You must be a Standard 1 Year member to access this content.
CMS advised Bruker while Kellerhals Carrard advised Chemspeed Technologies AG on this transaction. Bruker Corporation, a Nasdaq-listed company specialized in high-value analytical and diagnostic solutions at...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to Eulitha, Baker McKenzie advised AGIC Capital. Eulitha AG, a Swiss based nano technology provider of non-contact Nano-UV-Lithography equipment and...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to the buyer. Orell Füssli Group acquired a majority stake in hep Verlag and becomes the largest private Swiss publisher of...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard advised Vifor Pharma on this transaction. Vifor Pharma Participations AG (Vifor Pharma) closed its divestment transaction regarding its finished drug product manufacturing business with...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
You must be a Standard 1 Year member to access this content.
Kellerhals Carrard acted as legal advisor to STILLE in this transaction. Stille AB, a medical device company whose shares are listed on the Nasdaq First North...
You must be a Standard 1 Year member to access this content.
